165 related articles for article (PubMed ID: 15143346)
1. Omomyc expression in skin prevents Myc-induced papillomatosis.
Soucek L; Nasi S; Evan GI
Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
[TBL] [Abstract][Full Text] [Related]
2. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
4. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CCAAT/enhancer binding protein family DNA binding in mouse epidermis prevents and regresses papillomas.
Oh WJ; Rishi V; Orosz A; Gerdes MJ; Vinson C
Cancer Res; 2007 Feb; 67(4):1867-76. PubMed ID: 17308129
[TBL] [Abstract][Full Text] [Related]
6. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.
Carlson H; Ota S; Song Y; Chen Y; Hurlin PJ
Oncogene; 2002 May; 21(24):3827-35. PubMed ID: 12032820
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of myc and telomerase interactions in vivo.
Flores I; Evan G; Blasco MA
Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
[TBL] [Abstract][Full Text] [Related]
10. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.
Waikel RL; Wang XJ; Roop DR
Oncogene; 1999 Aug; 18(34):4870-8. PubMed ID: 10490820
[TBL] [Abstract][Full Text] [Related]
11. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
[TBL] [Abstract][Full Text] [Related]
12. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors.
Manjarrez ME; Ocadiz R; Valle L; Pacheco C; Marroquin A; De la Torre C; Selman M; Gariglio P
Clin Cancer Res; 2006 Dec; 12(23):6946-51. PubMed ID: 17145812
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
14. Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia.
Flores I; Murphy DJ; Swigart LB; Knies U; Evan GI
Oncogene; 2004 Aug; 23(35):5923-30. PubMed ID: 15208685
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
[TBL] [Abstract][Full Text] [Related]
16. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
17. Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells.
Cheung RS; Brooling JT; Johnson MM; Riehle KJ; Campbell JS; Fausto N
Carcinogenesis; 2007 Dec; 28(12):2624-31. PubMed ID: 17698969
[TBL] [Abstract][Full Text] [Related]
18. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
Jansen AP; Camalier CE; Colburn NH
Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
[TBL] [Abstract][Full Text] [Related]
19. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.
Knies-Bamforth UE; Fox SB; Poulsom R; Evan GI; Harris AL
Cancer Res; 2004 Sep; 64(18):6563-70. PubMed ID: 15374969
[TBL] [Abstract][Full Text] [Related]
20. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
Brennan D; Hu Y; Joubeh S; Choi YW; Whitaker-Menezes D; O'Brien T; Uitto J; Rodeck U; Mahoney MG
J Cell Sci; 2007 Mar; 120(Pt 5):758-71. PubMed ID: 17284515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
